Marginal ulcer after mini gastric by-pass and sleeve gastrectomy with transit bipartition

Abstract

The aim of this study to present the incidence of marginal ulcer among patients who underwent laparoscopic mini gastric by-pass (MGBP) or laparoscopic sleeve gastrectomy with transit bipartition (SG-TB), and to determine demographic, clinical and surgical risk factors associated with marginal ulcer development. This case-control study was designed as a retrospective analysis of an SG-TB and MGBP surgical series. The marginal ulcer group consisted of 8 patients who developed marginal ulcers during their follow-up. The control group was formed with a randomly selected sample of 18 people matching according to age, sex and operation type among the remaining 626 patients. The median age of all patients included in the study was 51 (27-62) years. 75.0% of the marginal ulcer group and 66.7% of the control group were males (p = 1.000). Marginal ulcer developed in 1.26% of all patients who underwent bariatric-metabolic surgery, in 6.45% of patients who underwent MGBP, and in 0.99% of patients who underwent SG-TB. It was observed that the ulcers of all cases recovered completely. No perforation was observed in any patient, no surgical intervention was required, and no marginal ulcer-related mortality was observed.There was no significant difference between the marginal ulcer group and the control group in terms of surgical, clinical and demographic features. Considering our practices and results, it was thought that post-operative PPI treatment for at least 6 months had a preventive effect on marginal ulcer development, and PPI treatment used after marginal ulcer development had an important role in healing.

Keywords

• Obesity
• marginal ulcer
• mini gastric by-pass
• sleeve gastrectomy with transit bipartition
• bariatric-metabolic surgery

References

1. 1. Deffieux X, De Tayrac R, Huel C, Bottero J, Gervaise A, Bonnet K, et al. Vaginal mesh erosion after transvaginal repair of cystocele using Gynemesh or Gynemesh-Soft in 138 women: a comparative study. Int Urogynecol J Pelvic Floor Dysfunct. 2007; 18(1): 73-9.
2. 2. Kumbhari V, Le Roux CW, Cohen RV. Endoscopic Evaluation and Management of Late Complications After Bariatric Surgery: a Narrative Review. Obes Surg. 2021; 31(10): 4624-33.
3. 3. Aviran E, Rayman S, Yehuda AB, Goitein D. Marginal ulcer causing delayed anastomotic perforation following one anastomosis gastric bypass (OAGB). Surg Obes Relat Dis. 2021; 17(2): 379-83.
4. 4. Clapp B, Hahn J, Dodoo C, Guerra A, De La Rosa E, Tyroch A. Evaluation of the rate of marginal ulcer formation after bariatric surgery using the MBSAQIP database. Surg Endosc. 2019; 33(6): 1890-7.
5. 5. Coblijn UK, Goucham AB, Lagarde SM, Kuiken SD, Van Wagensveld BA. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors, and patient presentation: a systematic review. Obes Surg. 2014; 24(2): 299-309.
6. 6. Skogar ML, Sundbom M. Nonsteroid anti-inflammatory drugs and the risk of peptic ulcers after gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis. 2022; 18(7): 888-93.
7. 7. Bekhali Z, Sundbom M. Low Risk for Marginal Ulcers in Duodenal Switch and Gastric Bypass in a Well-Defined Cohort of 472 Patients. Obes Surg. 2020; 30(11): 4422-7.
8. 8. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Aminian A, Brethauer SA, et al. Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes. N Engl J Med. 2017; 376(7): 641-51.

9. 9. Madsbad S, Holst JJ. Bariatric surgery-which procedure is the optimal choice? Lancet. 2019; 393(10178): 1263-4.
10. 10. Parmar CD, Mahawar KK. One Anastomosis (Mini) Gastric Bypass Is Now an Established Bariatric Procedure: a Systematic Review of 12,807 Patients. Obes Surg. 2018; 28(9): 2956-67.
11. 11. Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian sub-continent. Obes Surg. 2014; 24(10): 1724-8.
12. 12. Santoro S. Adaptive and neuroendocrine procedures: a new pathway in bariatric and metabolic surgery. Obes Surg. 2008; 18(10): 1343-5.
13. 13. Di Palma A, Liu B, Maeda A, Anvari M, Jackson T, Okrainec A. Marginal ulceration following Roux-en-Y gastric bypass: risk factors for ulcer development, recurrence and need for revisional surgery. Surg Endosc. 2021; 35(5): 2347-53.
14. 14. Mahawar KK, Reed AN, Graham YNH. Marginal ulcers after one anastomosis (mini) gastric bypass: a survey of surgeons. Clin Obes. 2017; 7(3): 151-6.
15. 15. Santoro S, Castro LC, Velhote MC, Malzoni CE, Klajner S, Castro LP, et al. Sleeve gastrectomy with transit bipartition: a potent intervention for metabolic syndrome and obesity. Ann Surg. 2012; 256(1): 104-10.
16. 16. Ece I, Yilmaz H, Yormaz S, Çolak B, Calisir A, Sahin M. The Short-Term Effects of Transit Bipartition with Sleeve Gastrectomy and Distal-Roux-en-Y Gastric Bypass on Glycemic Control, Weight Loss, and Nutritional Status in Morbidly Obese and Type 2 Diabetes Mellitus Patients. Obes Surg. 2021; 31(5): 2062-71.
17. 17. Coblijn UK, Lagarde SM, De Castro SM, Kuiken SD, Van Tets WF, Van Wagensveld BA. The influence of prophylactic proton pump inhibitor treatment on the development of symptomatic marginal ulceration in Roux-en-Y gastric bypass patients: a historic cohort study. Surg Obes Relat Dis. 2016; 12(2): 246-52.
18. 18. Topart P, Becouarn G, Finel JB. Comparison of 2-Year Results of Roux-en-Y Gastric Bypass and Transit Bipartition with Sleeve Gastrectomy for Superobesity. Obes Surg. 2020; 30(9): 3402-7.
19. 19. Palermo M, Acquafresca PA, Rogula T, Duza GE, Serra E. Late surgical complications after gastric by-pass: a literature review. Arq Bras Cir Dig. 2015; 28(2): 139-43.
20. 20. Moon RC, Teixeira AF, Goldbach M, Jawad MA. Management and treatment outcomes of marginal ulcers after Roux-en-Y gastric bypass at a single high volume bariatric center. Surg Obes Relat Dis. 2014; 10(2): 229-34.
21. 21. Azagury DE, Abu Dayyeh BK, Greenwalt IT, Thompson CC. Marginal ulceration after Roux-en-Y gastric bypass surgery: characteristics, risk factors, treatment, and outcomes. Endoscopy. 2011; 43(11): 950-4.
22. 22. Baksi A, Kamtam DNH, Aggarwal S, Ahuja V, Kashyap L, Shende DR. Should Surveillance Endoscopy Be Routine After One Anastomosis Gastric Bypass to Detect Marginal Ulcers: Initial Outcomes in a Tertiary Referral Centre. Obes Surg. 2020; 30(12): 4974-80.
23. 23. Coblijn UK, Lagarde SM, De Castro SM, Kuiken SD, Van Wagensveld BA. Symptomatic marginal ulcer disease after Roux-en-Y gastric bypass: incidence, risk factors and management. Obes Surg. 2015; 25(5): 805-11.
24. 24. Noun R, Skaff J, Riachi E, Daher R, Antoun NA, Nasr M. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012; 22(5): 697-703.
25. 25. Kalaiselvan R, Exarchos G, Hamza N, Ammori BJ. Incidence of perforated gastrojejunal anastomotic ulcers after laparoscopic gastric bypass for morbid obesity and role of laparoscopy in their management. Surg Obes Relat Dis. 2012; 8(4): 423-8.
26. 26. Sverdén E, Mattsson F, Sondén A, Leinsköld T, Tao W, Lu Y, et al. Risk Factors for Marginal Ulcer After Gastric Bypass Surgery for Obesity: A Population-based Cohort Study. Ann Surg. 2016; 263(4): 733-7.
27. 27. Dittrich L, Schwenninger MV, Dittrich K, Pratschke J, Aigner F, Raakow J. Marginal ulcers after laparoscopic Roux-en-Y gastric bypass: analysis of the amount of daily and lifetime smoking on postoperative risk. Surg Obes Relat Dis. 2020; 16(3): 389-96.
28. 28. Yuce TK, Khorfan R, Soper NJ, Hungness ES, Nagle AP, Teitelbaum EN, et al. Post-Operative Complications and Readmissions Associated with Smoking Following Bariatric Surgery. J Gastrointest Surg. 2020; 24(3): 525-30.
29. 29. Kang X, Zurita-Macias L, Hong D, Cadeddu M, Anvari M, Gmora S. A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2016; 12(5): 1003-7.
30. 30. Parmar CD, Mahawar KK, Boyle M, Carr WR, Jennings N, Schroeder N, et al. Mini Gastric Bypass: first report of 125 consecutive cases from United Kingdom. Clin Obes. 2016; 6(1): 61-7.
31. 31. Scheffel O, Daskalakis M, Weiner RA. Two important criteria for reducing the risk of postoperative ulcers at the gastrojejunostomy site after gastric bypass: patient compliance and type of gastric bypass. Obes Facts. 2011; 4 Suppl 1(Suppl 1): 39-41.
32. 32. Mahawar KK, Jennings N, Brown J, Gupta A, Balupuri S, Small PK. "Mini" gastric bypass: systematic review of a controversial procedure. Obes Surg. 2013; 23(11): 1890-8.
33. 33. Mahawar KK, Borg CM, Kular KS, Courtney MJ, Sillah K, Carr WRJ, et al. Understanding Objections to One Anastomosis (Mini) Gastric Bypass: A Survey of 417 Surgeons Not Performing this Procedure. Obes Surg. 2017; 27(9): 2222-8.